Dose Optimized BNCT for Head and Neck Cancer

NCT05883007 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Head and Neck Cancer
Squamous Cell Carcinoma

Interventions

RADIATION: Accelerator-based BNCT with borofalan(10B)

Sponsor

Southern Tohoku BNCT Research Center